{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:07:19Z","timestamp":1785402439431,"version":"3.56.0"},"reference-count":29,"publisher":"IMR Press","issue":"7","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br. J. Hosp. Med. (Lond)"],"abstract":"<jats:p>Aims\/Background:Coronary artery disease (CAD) has been epidemiologically linked to idiopathic pulmonary fibrosis (IPF); however, the genetic basis of this association remains unclear. Therefore, this study aims to investigate the potential causal relationships between IPF and CAD using a bidirectional two-sample Mendelian randomization (MR) strategy.Methods:Inverse-variance weighted (IVW), MR-Egger, weighted median, and weighted mode approaches were applied to summary statistics obtained from CAD and IPF genome-wide association studies. Heterogeneity among instrumental variables was assessed using Cochran\u2019s Q test. Pleiotropy was assessed using MR-Egger regression and MR pleiotropy residual sum and outlier (MR-PRESSO) analyses. Additionally, the robustness and reliability of the findings were validated by applying a leave-one-out analysis.Results:The forward MR analysis revealed no evidence supporting a genetic causal association between IPF and CAD (odds ratio [OR] = 0.989, 95% confidence interval [CI]: 0.967\u20131.010, p = 0.305) after excluding an outlier single-nucleotide polymorphism (SNP) (rs7725218). However, reverse MR analysis demonstrated a significant negative genetic causal association between CAD and IPF (OR = 0.832, 95% CI: 0.711\u20130.975, p = 0.023). Sensitivity analysis revealed heterogeneity in the forward MR analysis, which was resolved after excluding an outlier SNP, with no evidence of horizontal pleiotropy detected.Conclusion:This study demonstrates a potential negative genetic influence of CAD on the risk of IPF, providing valuable insights that may guide the development of more enhanced preventive and therapeutic strategies. Future research should further assess the interactions between CAD and IPF to improve disease management and patient outcomes.<\/jats:p>","DOI":"10.31083\/bjhm56025","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:59:43Z","timestamp":1785398383000},"source":"Crossref","is-referenced-by-count":0,"title":["Causal Association Between Idiopathic Pulmonary Fibrosis and Coronary Artery Disease: A Bidirectional Two-Sample Mendelian Randomization"],"prefix":"10.31083","volume":"87","author":[{"given":"Lirui","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 101118 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 101118 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 101118 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8225-4447","authenticated-orcid":true,"given":"Jiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 101118 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Lynch JP III, Huynh RH, Fishbein MC, Saggar R, Belperio JA, Weigt SS. Idiopathic Pulmonary Fibrosis: Epidemiology, Clinical Features, Prognosis, and Management. Seminars in Respiratory and Critical Care Medicine. 2016; 37: 331\u2013357.","DOI":"10.1055\/s-0036-1582011"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Milioli G, Bosi M, Poletti V, Tomassetti S, Grassi A, Riccardi S, et al. Sleep and respiratory sleep disorders in idiopathic pulmonary fibrosis. Sleep Medicine Reviews. 2016; 26: 57\u201363.","DOI":"10.1016\/j.smrv.2015.03.005"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Mortimer KM, Bartels DB, Hartmann N, Capapey J, Yang J, Gately R, et al. Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data. Respiration; International Review of Thoracic Diseases. 2020; 99: 108\u2013118.","DOI":"10.1159\/000504630"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Surendran A, Huang C, Liu L. Circular RNAs and their roles in idiopathic pulmonary fibrosis. Respiratory Research. 2024; 25: 77.","DOI":"10.1186\/s12931-024-02716-2"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, et al. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2025; 151: e41\u2013e660.","DOI":"10.1161\/CIR.0000000000001303"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Kato S, Kitamura H, Hayakawa K, Fukui K, Tabata E, Otoshi R, et al. Coronary artery disease and heart failure in patients with idiopathic pulmonary fibrosis. Heart and Vessels. 2021; 36: 1151\u20131158.","DOI":"10.1007\/s00380-021-01787-1"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Nathan SD, Basavaraj A, Reichner C, Shlobin OA, Ahmad S, Kiernan J, et al. Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. Respiratory Medicine. 2010; 104: 1035\u20131041.","DOI":"10.1016\/j.rmed.2010.02.008"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Bray K, Bodduluri S, Kim YI, Sthanam V, Nath H, Bhatt SP. Idiopathic pulmonary fibrosis is more strongly associated with coronary artery disease than chronic obstructive pulmonary disease. Respiratory Medicine. 2023; 211: 107195.","DOI":"10.1016\/j.rmed.2023.107195"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ (Clinical Research Ed.). 2021; 375: n2233.","DOI":"10.1136\/bmj.n2233"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Nikpay M, Goel A, Won HH, Hall LM, Willenborg C, Kanoni S, et al. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nature Genetics. 2015; 47: 1121\u20131130.","DOI":"10.1038\/ng.3396"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Allen RJ, Guillen-Guio B, Oldham JM, Ma SF, Dressen A, Paynton ML, et al. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 2020; 201: 564\u2013574.","DOI":"10.1164\/rccm.201905-1017OC"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. American Journal of Respiratory and Critical Care Medicine. 2022; 205: e18\u2013e47.","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Li J, Zhang C, Tang J, He M, He C, Pu G, et al. Causal associations between gut microbiota, metabolites and asthma: a two-sample Mendelian randomization study. BMC Pulmonary Medicine. 2024; 24: 72.","DOI":"10.1186\/s12890-024-02898-x"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Li Y, Yang S, Liao M, Zheng Z, Li M, Wei X, et al. Association between genetically predicted leukocyte telomere length and non-scarring alopecia: A two-sample Mendelian randomization study. Frontiers in Immunology. 2023; 13: 1072573.","DOI":"10.3389\/fimmu.2022.1072573"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Burgess S, Thompson SG, CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. International Journal of Epidemiology. 2011; 40: 755\u2013764.","DOI":"10.1093\/ije\/dyr036"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Luo Q, Chen J, Qin L, Luo Y, Zhang Y, Yang X, et al. Psoriasis may increase the risk of lung cancer: a two-sample Mendelian randomization study. Journal of the European Academy of Dermatology and Venereology. 2022; 36: 2113\u20132119.","DOI":"10.1111\/jdv.18437"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Xu J, Zhang S, Tian Y, Si H, Zeng Y, Wu Y, et al. Genetic Causal Association between Iron Status and Osteoarthritis: A Two-Sample Mendelian Randomization. Nutrients. 2022; 14: 3683.","DOI":"10.3390\/nu14183683"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. International Journal of Epidemiology. 2017; 46: 1985\u20131998.","DOI":"10.1093\/ije\/dyx102"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Greco M FD, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Statistics in Medicine. 2015; 34: 2926\u20132940.","DOI":"10.1002\/sim.6522"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nature Genetics. 2018; 50: 693\u2013698.","DOI":"10.1038\/s41588-018-0099-7"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Kizer JR, Zisman DA, Blumenthal NP, Kotloff RM, Kimmel SE, Strieter RM, et al. Association between pulmonary fibrosis and coronary artery disease. Archives of Internal Medicine. 2004; 164: 551\u2013556.","DOI":"10.1001\/archinte.164.5.551"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Carter P, Lagan J, Fortune C, Bhatt DL, Vestbo J, Niven R, et al. Association of Cardiovascular Disease With Respiratory Disease. Journal of the American College of Cardiology. 2019; 73: 2166\u20132177.","DOI":"10.1016\/j.jacc.2018.11.063"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Ackermann M, Werlein C, Plucinski E, Leypold S, K\u00fchnel MP, Verleden SE, et al. The role of vasculature and angiogenesis in respiratory diseases. Angiogenesis. 2024; 27: 293\u2013310.","DOI":"10.1007\/s10456-024-09910-2"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Ohayon L, Zhang X, Dutta P. The role of extracellular vesicles in regulating local and systemic inflammation in cardiovascular disease. Pharmacological Research. 2021; 170: 105692.","DOI":"10.1016\/j.phrs.2021.105692"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ (Clinical Research Ed.). 2018; 362: k601.","DOI":"10.1136\/bmj.k601"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Jiang Y, Chen R, Xu S, Ding Y, Zhang M, Bao M, et al. Endocrine and metabolic factors and the risk of idiopathic pulmonary fibrosis: a Mendelian randomization study. Frontiers in Endocrinology. 2024; 14: 1321576.","DOI":"10.3389\/fendo.2023.1321576"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Haidar A, Horwich T. Obesity, Cardiorespiratory Fitness, and Cardiovascular Disease. Current Cardiology Reports. 2023; 25: 1565\u20131571.","DOI":"10.1007\/s11886-023-01975-7"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Caama\u00f1o-Navarrete F, Jerez-Mayorga D, Alvarez C, Del-Cuerpo I, Cresp-Barr\u00eda M, Delgado-Floody P. Muscle Quality Index in Morbidly Obesity Patients Related to Metabolic Syndrome Markers and Cardiorespiratory Fitness. Nutrients. 2023; 15: 2458.","DOI":"10.3390\/nu15112458"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Kawamura T, Radak Z, Tabata H, Akiyama H, Nakamura N, Kawakami R, et al. Associations between cardiorespiratory fitness and lifestyle-related factors with DNA methylation-based ageing clocks in older men: WASEDA'S Health Study. Aging Cell. 2024; 23: e13960.","DOI":"10.1111\/acel.13960"}],"container-title":["British Journal of Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/7\/10.31083\/BJHM56025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:59:56Z","timestamp":1785398396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/7\/10.31083\/BJHM56025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1750-8460(26)03338-0"],"URL":"https:\/\/doi.org\/10.31083\/bjhm56025","relation":{},"ISSN":["1750-8460","1759-7390"],"issn-type":[{"value":"1750-8460","type":"print"},{"value":"1759-7390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"article-number":"56025"}}